Martek Announces Vaalia's My First Yoghurt with life'sDHA from Parmalat Australia
DHA omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life.
16/03/07 DHA omega-3 innovator Martek Biosciences Corporation announced that Parmalat Australia Ltd. has launched Vaalia My First Yoghurt with life'sDHA. Now available in major supermarket chains throughout Australia, Vaalia My First Yoghurt features 36mg of life'sDHA per 60g serving for infant brain and eye health.
Parmalat Australia is a wholly owned subsidiary of Parmalat SpA, an Italian-based global dairy company with major operations in Europe, Latin America, North America and Australia. Its worldwide operations include almost 140 production centers and more than 36,000 employees.
In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to make the use of life'sDHA in food and beverages a commercial success.
"Vaalia My First Yoghurt with life'sDHA demonstrates the growing global awareness of the health benefits of DHA for infants and children," said Steve Dubin, CEO of Martek Biosciences. "Martek is pleased to be working with Parmalat Australia Ltd., one of the largest dairy manufacturers in Australia."
DHA omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye function, and there are studies currently underway to investigate its role in decreasing the prevalence of certain neurological disorders.
